Pharmaceuticals, Biotechnology and Life Sciences
Circassia Pharmaceuticals Inc. has launched Duaklir, aclidinium bromide and formoterol fumarate, for the maintenance treatment of patients with chronic obstructive…
Label Updated to Include Reduction in Exacerbations and Major Adverse Cardiovascular Event Safety Data in Cardiovascular-Risk COPD Patients MORRISVILLE, N.C.–(BUSINESS…
Circassia Pharmaceuticals showed positive clinical data from two studies of Tudorza and Duaklir, nearing the a deal with AstraZeneca in the United…
Circassia Pharmaceuticals’s study of house dust mite allergy immunotherapy phase IIb field study failed to meed its primary endpoint, the company said Tuesday.